Atlas Trials

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Clinical trial NCT02762266 · TERMINATED

Trial details

NCT number
NCT02762266
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Child-Pugh Class AChild-Pugh Class BRecurrent Hepatocellular Carcinoma
Start date
2016-02-27
Primary completion
2022-12-31
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.